Class IIOngoingD-0554-2023
Drug recall · May 3, 2023
Tadalafil Tablets recall
Why: CGMP Deviations
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Tadalafil Tablets, USP 5 mg, 30-count bottles, Rx Only, Repackaged By: Northwind Pharmaceuticals, Indianapolis, IN 46203. NDC 51655-487-52
- Lots / codes
Lot #: F114302001, Exp. Date 05/31/2023
- Quantity
- 23 bottles
- Company
- Northwind Pharmaceuticals LLC, Indianapolis, IN
- Distribution
- Nationwide with the United States
- Initiated
- March 16, 2023 · Voluntary: Firm initiated
- Classified
- April 26, 2023
- Reported
- May 3, 2023
- How notified
- Two or more of the following: Email, Fax, Letter, Press Release, Telephone, Visit
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Recalled with it (same recall event)
Class IIOngoingMay 3, 2023Atorvastatin Calcium TabletsNorthwind Pharmaceuticals LLC · D-0548-2023Class IIOngoingMay 3, 2023BusPIRone Hydrochloride Tablets USPNorthwind Pharmaceuticals LLC · D-0549-2023Class IIOngoingMay 3, 2023Doxazosin TabletsNorthwind Pharmaceuticals LLC · D-0550-2023Class IIOngoingMay 3, 2023Glimepiride TabletsNorthwind Pharmaceuticals LLC · D-0551-2023Class IIOngoingMay 3, 2023Glimepiride TabletsNorthwind Pharmaceuticals LLC · D-0552-2023Class IIOngoingMay 3, 2023Tadalafil TabletsNorthwind Pharmaceuticals LLC · D-0553-2023
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Tadalafil
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.